A new artificial intelligence model can improve the process of drug and vaccine discovery by predicting how efficiently ...

A new artificial intelligence model can improve the process of drug and vaccine discovery by predicting how efficiently ...

To meet the requirements for FDA Breakthrough Device Designation, CDx Diagnostics submitted technical and clinical evidence ...

It can take years for humans to solve complex scientific problems. With AI, it can take a fraction of the time.

Recursion Pharmaceuticals and Relay Therapeutics both leverage their respective AI drug discovery platforms to potentially develop novel therapeutic candidates.

RedChip Companies will air an interview with Lantern Pharma Inc. (Nasdaq:LTRN) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, July 26, at 7 p.m.

If you collect the data today, what can you read from it five years from now because the technology is advancing so quickly?” ...

FILE- Daniil Medvedev, of Russia, right, talks with Novak Djokovic, of Serbia, after defeating Djokovic in the men's singles ...

While the plan rarely mentions healthcare, it is one of the administration’s first steps to set federal policies, which ...

The Trump White House released a report outlining its plan to ensure that the United States remains a global leader in AI ...

On Wednesday, July 23, 2025, the Trump Administration released "Winning the AI Race: America's AI Action Plan," a 90-point policy framework that fundamentally reframes US artificial intelligence (AI) ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.